Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Fig. 4

Overall survival of 19 patients with peritoneal metastasis treated with CRS and HIPEC, with (green curve) or without (blue curve) “neoadjuvant” PIPAC. As expected, patients primarily not eligible for CRS and HIPEC and treated with neoadjuvant PIPAC seem to have a worse prognosis than the other patients. However, this difference does not reach statistical significance in this small cohort of patients

Back to article page